BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26772394)

  • 1. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
    Osman H; Cheng L; Ulbright TM; Idrees MT
    Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
    Wegman SJ; Parwani AV; Zynger DL
    Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
    Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
    Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein LIN28 is a marker for testicular germ cell tumors.
    Cao D; Allan RW; Cheng L; Peng Y; Guo CC; Dahiya N; Akhi S; Li J
    Hum Pathol; 2011 May; 42(5):710-8. PubMed ID: 21288558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
    Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
    Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
    Cao D; Humphrey PA; Allan RW
    Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
    Howitt BE; Brooks JD; Jones S; Higgins JP
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor.
    Xiao GQ; Li F; Unger PD; Katerji H; Yang Q; McMahon L; Burstein DE
    Mod Pathol; 2016 Jun; 29(6):591-8. PubMed ID: 26916077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDX2 expression in yolk sac component of testicular germ cell tumors.
    Bing Z; Pasha T; Tomaszewski JE; Zhang P
    Int J Surg Pathol; 2009 Oct; 17(5):373-7. PubMed ID: 19578052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
    Bu L; Yang Q; McMahon L; Xiao GQ; Li F
    Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of HNF1β in the differential diagnosis of yolk sac tumor from other germ cell tumors.
    Rougemont AL; Tille JC
    Hum Pathol; 2018 Nov; 81():26-36. PubMed ID: 29753846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
    Shojaei H; Hong H; Redline RW
    Mod Pathol; 2016 Oct; 29(10):1278-88. PubMed ID: 27443515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome.
    Kommoss F; Oliva E; Bittinger F; Kirkpatrick CJ; Amin MB; Bhan AK; Young RH; Scully RE
    Hum Pathol; 2000 Sep; 31(9):1055-61. PubMed ID: 11014571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
    Chang MC; Vargas SO; Hornick JL; Hirsch MS; Crum CP; Nucci MR
    Int J Gynecol Pathol; 2009 Jul; 28(4):347-55. PubMed ID: 19483629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases.
    Mei K; Liu A; Allan RW; Wang P; Lane Z; Abel TW; Wei L; Cheng H; Guo S; Peng Y; Rakheja D; Wang M; Ma J; Rodriguez MM; Li J; Cao D
    Mod Pathol; 2009 Dec; 22(12):1628-36. PubMed ID: 19820689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glypican 3: a novel marker in testicular germ cell tumors.
    Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
    Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
    Zhou Y; Rothrock A; Murugan P; Li F; Bu L
    Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.